Literature DB >> 28292726

Cell membrane-derived nanomaterials for biomedical applications.

Ronnie H Fang1, Yao Jiang1, Jean C Fang1, Liangfang Zhang2.   

Abstract

The continued evolution of biomedical nanotechnology has enabled clinicians to better detect, prevent, manage, and treat human disease. In order to further push the limits of nanoparticle performance and functionality, there has recently been a paradigm shift towards biomimetic design strategies. By taking inspiration from nature, the goal is to create next-generation nanoparticle platforms that can more effectively navigate and interact with the incredibly complex biological systems that exist within the body. Of great interest are cellular membranes, which play essential roles in biointerfacing, self-identification, signal transduction, and compartmentalization. In this review, we explore the major ways in which researchers have directly leveraged cell membrane-derived biomaterials for the fabrication of novel nanotherapeutics and nanodiagnostics. Such emerging technologies have the potential to significantly advance the field of nanomedicine, helping to improve upon traditional modalities while also enabling novel applications.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomimetic nanoparticle; Cell membrane; Detoxification; Drug delivery; Imaging; Immunotherapy

Mesh:

Year:  2017        PMID: 28292726      PMCID: PMC5417338          DOI: 10.1016/j.biomaterials.2017.02.041

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  239 in total

1.  A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.

Authors:  Colleen Olive; Michael R Batzloff; Anikó Horváth; Allan Wong; Timothy Clair; Penny Yarwood; Istvan Toth; Michael F Good
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

2.  Nanoerythrosomes, a new derivative of erythrocyte ghost: IV. Fate of reinjected nanoerythrosomes.

Authors:  J Désilets; A Lejeune; J Mercer; C Gicquaud
Journal:  Anticancer Res       Date:  2001 May-Jun       Impact factor: 2.480

3.  Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes.

Authors:  A Omolola Eniola; Stephen D Rodgers; Daniel A Hammer
Journal:  Biomaterials       Date:  2002-05       Impact factor: 12.479

4.  Role of CD47 as a marker of self on red blood cells.

Authors:  P A Oldenborg; A Zheleznyak; Y F Fang; C F Lagenaur; H D Gresham; F P Lindberg
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

5.  Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene.

Authors:  C S Cho; K Y Cho; I K Park; S H Kim; T Sasagawa; M Uchiyama; T Akaike
Journal:  J Control Release       Date:  2001-11-09       Impact factor: 9.776

6.  Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.

Authors:  Colleen Olive; Timothy Clair; Penny Yarwood; Michael F Good
Journal:  Vaccine       Date:  2002-06-21       Impact factor: 3.641

7.  Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice.

Authors:  S Kawakami; J Wong; A Sato; Y Hattori; F Yamashita; M Hashida
Journal:  Biochim Biophys Acta       Date:  2000-12-15

8.  Quantitative and reversible lectin-induced association of gold nanoparticles modified with alpha-lactosyl-omega-mercapto-poly(ethylene glycol).

Authors:  H Otsuka; Y Akiyama; Y Nagasaki; K Kataoka
Journal:  J Am Chem Soc       Date:  2001-08-29       Impact factor: 15.419

9.  Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat.

Authors:  A Rennermalm; Y H Li; L Bohaufs; C Jarstrand; A Brauner; F R Brennan; J I Flock
Journal:  Vaccine       Date:  2001-05-14       Impact factor: 3.641

10.  Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: In situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells.

Authors:  S A Linehan; L Martínez-Pomares; P D Stahl; S Gordon
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

View more
  72 in total

Review 1.  Engineering biological interactions on the nanoscale.

Authors:  Yao Jiang; Sanam Chekuri; Ronnie H Fang; Liangfang Zhang
Journal:  Curr Opin Biotechnol       Date:  2018-11-01       Impact factor: 9.740

2.  Dendritic Cell Membrane Vesicles for Activation and Maintenance of Antigen-Specific T Cells.

Authors:  Lukasz J Ochyl; James J Moon
Journal:  Adv Healthc Mater       Date:  2018-11-22       Impact factor: 9.933

3.  Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.

Authors:  Feihu Wang; Michael Porter; Alexandros Konstantopoulos; Pengcheng Zhang; Honggang Cui
Journal:  J Control Release       Date:  2017-09-25       Impact factor: 9.776

Review 4.  Direct Drug Targeting into Intracellular Compartments: Issues, Limitations, and Future Outlook.

Authors:  Gamaleldin I Harisa; Tarek M Faris
Journal:  J Membr Biol       Date:  2019-08-02       Impact factor: 1.843

Review 5.  Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

Authors:  Joon Ho Park; Diana Dehaini; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Nanoscale Horiz       Date:  2019-06-28       Impact factor: 10.989

Review 6.  Biomimetic Nanotechnology toward Personalized Vaccines.

Authors:  Jiarong Zhou; Ashley V Kroll; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Adv Mater       Date:  2019-06-17       Impact factor: 30.849

7.  Multiantigenic Nanotoxoids for Antivirulence Vaccination against Antibiotic-Resistant Gram-Negative Bacteria.

Authors:  Xiaoli Wei; Danni Ran; Anaamika Campeau; Crystal Xiao; Jiarong Zhou; Diana Dehaini; Yao Jiang; Ashley V Kroll; Qiangzhe Zhang; Weiwei Gao; David J Gonzalez; Ronnie H Fang; Liangfang Zhang
Journal:  Nano Lett       Date:  2019-06-11       Impact factor: 11.189

8.  Biomimetic Targeting of Nanoparticles to Immune Cell Subsets via Cognate Antigen Interactions.

Authors:  Brian T Luk; Yao Jiang; Jonathan A Copp; Che-Ming J Hu; Nishta Krishnan; Weiwei Gao; Shulin Li; Ronnie H Fang; Liangfang Zhang
Journal:  Mol Pharm       Date:  2018-03-16       Impact factor: 4.939

Review 9.  Crosstalk of Nanosystems Induced Extracellular Vesicles as Promising Tools in Biomedical Applications.

Authors:  Gamaleldin I Harisa; Mohamed M Badran; Fars K Alanazi; Sabry M Attia
Journal:  J Membr Biol       Date:  2017-11-10       Impact factor: 1.843

10.  Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.

Authors:  Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin
Journal:  Adv Funct Mater       Date:  2020-03-03       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.